Corrigendum
- PMID: 30927409
- DOI: 10.1093/europace/euz040
Corrigendum
Erratum for
-
Performance of idarucizumab as antidote of dabigatran in daily clinical practice.Europace. 2019 Mar 1;21(3):414-420. doi: 10.1093/europace/euy220. Europace. 2019. PMID: 30339226
Publication types
LinkOut - more resources
Full Text Sources